Free Access
Vet. Res.
Volume 40, Number 4, July-August 2009
Number of page(s) 16
Published online 14 March 2009
How to cite this article Vet. Res. (2009) 40:28
References of  Vet. Res. (2009) 40:28
  1. Adler B., Scrivano L., Ruzcics Z., Rupp B., Sinzger C., Koszinowski U., Role of human cytomeg alovirus UL131A in cell type-specific virus entry and release, J. Gen. Virol. (2006) 87:2451–2460 [CrossRef] [PubMed].
  2. Buckmaster A.E., Scott S.D., Sanderson M.J., Boursnell M.E., Ross N.L., Binns M.M., Gene sequence and mapping data from Marek's disease virus and herpesvirus of turkeys: implications for herpesvirus classification, J. Gen. Virol. (1988) 69:2033–2042 [CrossRef] [PubMed].
  3. Calnek B.W., Adldinger H.K., Kahn D.E., Feather follicle epithelium: a source of enveloped and infectious cell-free herpesvirus from Marek's disease, Avian Dis. (1970) 14:219–233 [CrossRef] [PubMed].
  4. Churchill A.E., Biggs P.M., Agent of Marek's disease in tissue culture, Nature (1967) 215:528–530 [CrossRef] [PubMed].
  5. Churchill A.E., Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease, I. Studies in cell culture, J. Natl. Cancer Inst. (1968) 41:939–950 [PubMed].
  6. Churchill A.E., Biggs P.M., Herpes-type virus isolated in cell culture from tumors of chickens with Marek's disease. II. Studies in vivo, J. Natl. Cancer Inst. (1968) 41:951–956 [PubMed].
  7. Cohen J.I., Seidel K., Varicella-zoster virus (VZV) open reading frame 10 protein, the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro, J. Virol. (1994) 68:7850–7858 [PubMed].
  8. Datsenko K.A., Wanner B.L., One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products, Proc. Natl. Acad. Sci. USA (2000) 97:6640–6645 [CrossRef] [PubMed].
  9. Davison A.J., Evolution of the herpesviruses, Vet. Microbiol. (2002) 86:69–88 [CrossRef] [PubMed].
  10. Denesvre C., Blondeau C., Lemesle M., Le Vern Y., Vautherot D., Roingeard P., Vautherot J.F., Morphogenesis of a highly replicative EGFPVP22 recombinant Marek's disease virus in cell culture, J. Virol. (2007) 81:12348–12359 [CrossRef] [PubMed].
  11. Donnelly M., Elliott G., Fluorescent tagging of herpes simplex virus tegument protein VP13/14 in virus infection, J. Virol. (2001) 75:2575–2583 [CrossRef] [PubMed].
  12. Donnelly M., Elliott G., Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14, J. Virol. (2001) 75:2566–2574 [CrossRef] [PubMed].
  13. Dorange F., El Mehdaoui S., Pichon C., Coursaget P., Vautherot J.F., Marek's disease virus (MDV) homologues of herpes simplex virus type 1 UL49 (VP22) and UL48 (VP16) genes: high-level expression and characterization of MDV-1 VP22 and VP16, J. Gen. Virol. (2000) 81:2219–2230 [PubMed].
  14. Dorange F., Tischer B.K., Vautherot J.F., Osterrieder N., Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth, J. Virol. (2002) 76:1959–1970 [CrossRef] [PubMed].
  15. Goshima F., Watanabe D., Takakuwa H., Wada K., Daikoku T., Yamada M., Nishiyama Y., Herpes simplex virus UL17 protein is associated with B capsids and colocalizes with ICP35 and VP5 in infected cells, Arch. Virol. (2000) 145:417–426 [CrossRef] [PubMed].
  16. Himly M., Foster D.N., Bottoli I., Iacovoni J.S., Vogt P.K., The DF-1 chicken fibroblast cell line: transformation induced by diverse oncogenes and cell death resulting from infection by avian leukosis viruses, Virology (1998) 248:295–304 [CrossRef] [PubMed].
  17. Johannsen E., Luftig M., Chase M.R., Weicksel S., Cahir-McFarland E., Illanes D., et al., Proteins of purified Epstein-Barr virus, Proc. Natl. Acad. Sci. USA (2004) 101:16286–16291 [CrossRef] [PubMed].
  18. Klupp B.G., Granzow H., Karger A., Mettenleiter T.C., Identification, subviral localization, and functional characterization of the pseudorabies virus UL17 protein, J. Virol. (2005) 79:13442–13453 [CrossRef] [PubMed].
  19. Laemmli U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (1970) 227:680–685 [CrossRef] [PubMed].
  20. Lee E.C., Yu D., Martinez de Velasco J., Tessarollo L., Swing D.A., Court D.L., et al., A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA, Genomics (2001) 73:56–65 [CrossRef] [PubMed].
  21. Lee L.F., Wu P., Sui D., Ren D., Kamil J., Kung H.J., Witter R.L., The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus, Proc. Natl. Acad. Sci. USA (2000) 97:6091–6096 [CrossRef] [PubMed].
  22. Mossman K.L., Sherburne R., Lavery C., Duncan J., Smiley J.R., Evidence that herpes simplex virus VP16 is required for viral egress downstream of the initial envelopment event, J. Virol. (2000) 74:6287–6299 [CrossRef] [PubMed].
  23. Niman H.L., Houghten R.A., Walker L.E., Reisfeld R.A., Wilson I.A., Hogle J.M., Lerner R.A., Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition, Proc. Natl. Acad. Sci. USA (1983) 80:4949–4953 [CrossRef] [PubMed].
  24. Petherbridge L., Brown A.C., Baigent S.J., Howes K., Sacco M.A., Osterrieder N., Nair V.K., Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes, J. Virol. (2004) 78:13376–13380 [CrossRef] [PubMed].
  25. Rixon F.J., Addison C., McGregor A., Macnab S.J., Nicholson P., Preston V.G., Tatman J.D., Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins, J. Gen. Virol. (1996) 77:2251–2260 [CrossRef] [PubMed].
  26. Salmon B., Cunningham C., Davison A.J., Harris W.J., Baines J.D., The herpes simplex virus type 1 U(L)17 gene encodes virion tegument proteins that are required for cleavage and packaging of viral DNA, J. Virol. (1998) 72:3779–3788 [PubMed].
  27. Schumacher D., Tischer B.K., Fuchs W., Osterrieder N., Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant, J. Virol. (2000) 74:11088–11098 [CrossRef] [PubMed].
  28. Schumacher D., Tischer B.K., Reddy S.M., Osterrieder N., Glycoproteins E and I of Marek's disease virus serotype 1 are essential for virus growth in cultured cells, J. Virol. (2001) 75:11307–11318 [CrossRef] [PubMed].
  29. Schumacher D., Tischer B.K., Trapp S., Osterrieder N., The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown, J. Virol. (2005) 79:3987–3997 [CrossRef] [PubMed].
  30. Taus N.S., Salmon B., Baines J.D., The herpes simplex virus 1 UL 17 gene is required for localization of capsids and major and minor capsid proteins to intranuclear sites where viral DNA is cleaved and packaged, Virology (1998) 252:115–125 [CrossRef] [PubMed].
  31. Thurlow J.K., Rixon F.J., Murphy M., Targett-Adams P., Hughes M., Preston V.G., The herpes simplex virus type 1 DNA packaging protein UL17 is a virion protein that is present in both the capsid and the tegument compartments, J. Virol. (2005) 79:150–158 [CrossRef] [PubMed].
  32. Thurlow J.K., Murphy M., Stow N.D., Preston V.G., Herpes simplex virus type 1 DNA-packaging protein UL17 is required for efficient binding of UL25 to capsids, J. Virol. (2006) 80:2118–2126 [CrossRef] [PubMed].
  33. Tischer B.K., Schumacher D., Messerle M., Wagner M., Osterrieder N., The products of the UL10 (gM) and the UL49.5 genes of Marek's disease virus serotype 1 are essential for virus growth in cultured cells, J. Gen. Virol. (2002) 83:997–1003 [PubMed].
  34. Tischer B.K., Schumacher D., Chabanne-Vautherot D., Zelnik V., Vautherot J.F., Osterrieder N., High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro, J. Virol. (2005) 79:5889–5899 [CrossRef] [PubMed].
  35. Tischer B.K., von Einem J., Kaufer B., Osterrieder N., Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli, Biotechniques (2006) 40:191–197 [CrossRef] [PubMed].
  36. Tischer B.K., Kaufer B.B., Sommer M., Wussow F., Arvin A.M., Osterrieder N., A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9, J. Virol. (2007) 81:13200–13208 [CrossRef] [PubMed].
  37. Trus B.L., Newcomb W.W., Cheng N., Cardone G., Marekov L., Homa F.L., et al., Allosteric signaling and a nuclear exit strategy: binding of UL25/UL17 heterodimers to DNA-Filled HSV-1 capsids, Mol. Cell. (2007) 26:479–489 [CrossRef] [PubMed].
  38. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Rock D.L., Kutish G.F., The genome of a very virulent Marek's disease virus, J. Virol. (2000) 74:7980–7988 [CrossRef] [PubMed].
  39. Uzzau S., Figueroa-Bossi N., Rubino S., Bossi L., Epitope tagging of chromosomal genes in Salmonella, Proc. Natl. Acad. Sci. USA (2001) 98:15264–15269 [CrossRef] [PubMed].
  40. Varnum S.M., Streblow D.N., Monroe M.E., Smith P., Auberry K.J., Pasa-Tolic L., et al., Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome, J. Virol. (2004) 78:10960–10966 [CrossRef] [PubMed].
  41. Vittone V., Diefenbach E., Triffett D., Douglas M.W., Cunningham A.L., Diefenbach R.J., Determination of interactions between tegument proteins of herpes simplex virus type 1, J. Virol. (2005) 79:9566–9571 [CrossRef] [PubMed].
  42. Weinheimer S.P., Boyd B.A., Durham S.K., Resnick J.L., O'Boyle D.R. 2nd, Deletion of the VP16 open reading frame of herpes simplex virus type 1, J. Virol. (1992) 66:258–269 [PubMed].
  43. Yamauchi Y., Wada K., Goshima F., Takakuwa H., Daikoku T., Yamada M., Nishiyama Y., The UL14 protein of herpes simplex virus type 2 translocates the minor capsid protein VP26 and the DNA cleavage and packaging UL33 protein into the nucleus of coexpressing cells, J. Gen. Virol. (2001) 82:321–330 [PubMed].